Copyright Reports & Markets. All rights reserved.

Global Cystic Fibrosis Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Cystic Fibrosis Drugs Market Overview

      • 1.1 Product Overview and Scope of Cystic Fibrosis Drugs
      • 1.2 Cystic Fibrosis Drugs Segment by Type
        • 1.2.1 Global Cystic Fibrosis Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injection
      • 1.3 Cystic Fibrosis Drugs Segment by Application
        • 1.3.1 Cystic Fibrosis Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Other
      • 1.3 Global Cystic Fibrosis Drugs Market by Region
        • 1.3.1 Global Cystic Fibrosis Drugs Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Cystic Fibrosis Drugs Market Size
        • 1.4.1 Global Cystic Fibrosis Drugs Revenue (2014-2025)
        • 1.4.2 Global Cystic Fibrosis Drugs Production (2014-2025)

      2 Global Cystic Fibrosis Drugs Market Competition by Manufacturers

      • 2.1 Global Cystic Fibrosis Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Cystic Fibrosis Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Cystic Fibrosis Drugs Production Sites, Area Served, Product Types
      • 2.5 Cystic Fibrosis Drugs Market Competitive Situation and Trends
        • 2.5.1 Cystic Fibrosis Drugs Market Concentration Rate
        • 2.5.2 Cystic Fibrosis Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Cystic Fibrosis Drugs Production Market Share by Regions

      • 3.1 Global Cystic Fibrosis Drugs Production Market Share by Regions
      • 3.2 Global Cystic Fibrosis Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Cystic Fibrosis Drugs Production
        • 3.4.1 North America Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Cystic Fibrosis Drugs Production
        • 3.5.1 Europe Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Cystic Fibrosis Drugs Production (2014-2019)
        • 3.6.1 China Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Cystic Fibrosis Drugs Production (2014-2019)
        • 3.7.1 Japan Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Cystic Fibrosis Drugs Consumption by Regions

      • 4.1 Global Cystic Fibrosis Drugs Consumption by Regions
      • 4.2 North America Cystic Fibrosis Drugs Consumption (2014-2019)
      • 4.3 Europe Cystic Fibrosis Drugs Consumption (2014-2019)
      • 4.4 China Cystic Fibrosis Drugs Consumption (2014-2019)
      • 4.5 Japan Cystic Fibrosis Drugs Consumption (2014-2019)

      5 Global Cystic Fibrosis Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Cystic Fibrosis Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Cystic Fibrosis Drugs Price by Type (2014-2019)
      • 5.4 Global Cystic Fibrosis Drugs Production Growth by Type (2014-2019)

      6 Global Cystic Fibrosis Drugs Market Analysis by Applications

      • 6.1 Global Cystic Fibrosis Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Cystic Fibrosis Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Cystic Fibrosis Drugs Business

      • 7.1 Actavis
        • 7.1.1 Actavis Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.1.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.1.3 Actavis Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 F. Hoffmann-La Roche
        • 7.2.1 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.2.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Gilead Sciences
        • 7.3.1 Gilead Sciences Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.3.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.3.3 Gilead Sciences Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novartis
        • 7.4.1 Novartis Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.4.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.4.3 Novartis Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Vertex Pharmaceuticals
        • 7.5.1 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.5.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Abbott
        • 7.6.1 Abbott Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.6.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.6.3 Abbott Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Anthera Pharmaceuticals
        • 7.7.1 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.7.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Arcturus Therapeutics
        • 7.8.1 Arcturus Therapeutics Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.8.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Boehringer Ingelheim
        • 7.9.1 Boehringer Ingelheim Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.9.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Chiesi Farmaceutici
        • 7.10.1 Chiesi Farmaceutici Cystic Fibrosis Drugs Production Sites and Area Served
        • 7.10.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
        • 7.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Corbus Pharmaceuticals
      • 7.12 Genzyme
      • 7.13 Insmed
      • 7.14 Johnson & Johnson
      • 7.15 Merck Sharp & Dohme
      • 7.16 Neovii Biotech
      • 7.17 Novo Nordisk
      • 7.18 PharmaSwiss
      • 7.19 Pharmaxis
      • 7.20 Proteostasis Therapeutics
      • 7.21 PTC Therapeutics
      • 7.22 United Medical
      • 7.23 Venus Remedies

      8 Cystic Fibrosis Drugs Manufacturing Cost Analysis

      • 8.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
      • 8.4 Cystic Fibrosis Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Cystic Fibrosis Drugs Distributors List
      • 9.3 Cystic Fibrosis Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Cystic Fibrosis Drugs Market Forecast

      • 11.1 Global Cystic Fibrosis Drugs Production, Revenue Forecast
        • 11.1.1 Global Cystic Fibrosis Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Cystic Fibrosis Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Cystic Fibrosis Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Cystic Fibrosis Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Cystic Fibrosis Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Cystic Fibrosis Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Cystic Fibrosis Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Cystic Fibrosis Drugs market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Cystic Fibrosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cystic Fibrosis Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Actavis
        F. Hoffmann-La Roche
        Gilead Sciences
        Novartis
        Vertex Pharmaceuticals
        Abbott
        Anthera Pharmaceuticals
        Arcturus Therapeutics
        Boehringer Ingelheim
        Chiesi Farmaceutici
        Corbus Pharmaceuticals
        Genzyme
        Insmed
        Johnson & Johnson
        Merck Sharp & Dohme
        Neovii Biotech
        Novo Nordisk
        PharmaSwiss
        Pharmaxis
        Proteostasis Therapeutics
        PTC Therapeutics
        United Medical
        Venus Remedies

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oral
        Injection

        Segment by Application
        Hospitals
        Clinics
        Other

        Buy now